Crinetics Pharmaceuticals, Inc. Income Tax Examination, Penalties and Interest Expense
Crinetics Pharmaceuticals, Inc. (CRNX) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2025-02-27
- Crinetics Pharmaceuticals, Inc. income tax examination, penalties and interest expense for fiscal 2024 was $0.00.
- Crinetics Pharmaceuticals, Inc. income tax examination, penalties and interest expense for fiscal 2023 was $0.00.
- Crinetics Pharmaceuticals, Inc. income tax examination, penalties and interest expense for fiscal 2022 was $0.00.
- Crinetics Pharmaceuticals, Inc. income tax examination, penalties and interest expense for fiscal 2021 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-13 |